Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-12-30
|
pubmed:abstractText |
The proportion of prostate cancer patients undergoing radical prostatectomy has increased over the past 10 to 15 years. It is conceivable that a corresponding increase in local tumor recurrences after prostatectomies will be observed. The role of salvage radiotherapy is presently unclear. In this study, the results of salvage radiotherapy for patients with biochemical evidence of local recurrence, as evidenced from rising prostate-specific antigen (PSA) levels, after radical prostatectomy at UCLA Medical Center and the West Los Angeles Veterans Administration Medical Center are described.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1081-4442
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
324-30
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9815297-Analysis of Variance,
pubmed-meshheading:9815297-Combined Modality Therapy,
pubmed-meshheading:9815297-Follow-Up Studies,
pubmed-meshheading:9815297-Humans,
pubmed-meshheading:9815297-Male,
pubmed-meshheading:9815297-Neoplasm Recurrence, Local,
pubmed-meshheading:9815297-Prostate-Specific Antigen,
pubmed-meshheading:9815297-Prostatectomy,
pubmed-meshheading:9815297-Prostatic Neoplasms,
pubmed-meshheading:9815297-Radiotherapy,
pubmed-meshheading:9815297-Salvage Therapy
|
pubmed:articleTitle |
Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
|
pubmed:affiliation |
Department of Radiation Therapy, University of California, Los Angeles Medical Center 90095, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|